NCT05966948View on ClinicalTrials.gov

HDP vs NS Intra-articular Injection Among KOA With Obese Patient

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 1, 2023

Conditions

Knee OsteoarthritisObesity

Interventions

DRUG

Dextrose Solution

Prolotherapy is a regenerative tissue therapy that is considered efficacious for reducing the symptoms and morbidity of Knee Osteoarthritis (KOA) using hypertonic dextrose as an injectable substance. Treatment will be given two times, on day 1st and 30th day.

DRUG

Normal Saline

Normal Saline will be intra-articular injected and given two times, on day 1st and 30th day.

Trial Locations (1)

Unknown

Rumah Sakit Umum Daerah Haji Provinsi Jawa Timur, Indonesia, Surabaya

All Listed Sponsors

lead

Rumah Sakit Umum Daerah Haji Provinsi Jawa Timur, Indonesia

OTHER

NCT05966948 - HDP vs NS Intra-articular Injection Among KOA With Obese Patient | Biotech Hunter | Biotech Hunter